InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

- Current share price for NTI : $0.012

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19 Q&A with NTI Company Chairman, Brian Leedman 20 Jan 2021 9:41AM $0.052 $0.012 fallen by 76.92%
$19 Change of Director's Interest Notice 22 Dec 2020 5:59PM $0.036 $0.012 fallen by 66.67%
$19 Appendix 2A 22 Dec 2020 5:50PM $0.036 $0.012 fallen by 66.67%
$19 Results of Meeting 22 Dec 2020 2:16PM $0.037 $0.012 fallen by 67.57%
$19 Successful Completion of In Vitro Studies 21 Dec 2020 9:39AM $0.052 $0.012 fallen by 76.92%
$19 Change of Director's Interest Notice x 3 17 Dec 2020 4:54PM $0.056 $0.012 fallen by 78.57%
$19 Update - Proposed issue of Securities - NTI 17 Dec 2020 4:51PM $0.056 $0.012 fallen by 78.57%
$19 Update - Proposed issue of Securities - NTI 17 Dec 2020 4:44PM $0.056 $0.012 fallen by 78.57%
$19 Disclosure Document 16 Dec 2020 6:54PM $0.058 $0.012 fallen by 79.31%
$19 Appendix 2A 11 Dec 2020 7:47PM $0.050 $0.012 fallen by 76%
$19 Results of Meeting 30 Nov 2020 7:47PM $0.029 $0.012 fallen by 58.62%
$19 Reinstatement to Official Quotation 30 Nov 2020 9:46AM $0.029 $0.012 fallen by 58.62%
$19 Further Success with Preliminary In-vitro Studies 30 Nov 2020 9:46AM $0.029 $0.012 fallen by 58.62%
$19 Voluntary Suspension 27 Nov 2020 9:57AM $0.029 $0.012 fallen by 58.62%
$19 Trading Halt 24 Nov 2020 7:17PM $0.029 $0.012 fallen by 58.62%
$19 Notice of General Meeting/Proxy Form 23 Nov 2020 5:15PM $0.029 $0.012 fallen by 58.62%
$19 Initiation of Clinical Product Formulation Studies 19 Nov 2020 8:28AM $0.027 $0.012 fallen by 55.56%
$19 Investor Presentation 16 Nov 2020 8:33AM $0.030 $0.012 fallen by 60%
$19 Ceasing to be a substantial holder x2 13 Nov 2020 6:21PM $0.030 $0.012 fallen by 60%
$19 Appendix 2A 12 Nov 2020 6:09PM $0.024 $0.012 fallen by 50%
$19 Quarterly Report and Appendix 4C - Additional Information 12 Nov 2020 5:51PM $0.024 $0.012 fallen by 50%
$19 Disclosure Document 6 Nov 2020 1:49PM $0.025 $0.012 fallen by 52%
$19 Appendix 2A 6 Nov 2020 1:09PM $0.025 $0.012 fallen by 52%
$19 Proposed issue of Securities - NTI 2 Nov 2020 9:59AM $0.026 $0.012 fallen by 53.85%
$19 Proposed issue of Securities - NTI 2 Nov 2020 9:58AM $0.026 $0.012 fallen by 53.85%

426 - 450 of 693 results

Page 18 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.